Veracyte logo
VCYTVeracyte
Trade VCYT now
Veracyte primary media

About Veracyte

Veracyte (NASDAQ:VCYT) is a diagnostic company that focuses on delivering genomic solutions to improve patient outcomes and reduce healthcare costs. It specializes in developing tests for the early detection of cancer and other diseases, providing physicians with actionable insights for patient care. Veracyte's portfolio includes tests for thyroid cancer, lung cancer, and idiopathic pulmonary fibrosis, among others. The company is committed to expanding its product range and enhancing its global presence through strategic partnerships and research advancements. Its operations span from the development and commercialization of its tests to collaborating with biopharmaceutical companies for companion diagnostic development. Veracyte aims to transform the diagnostic landscape by offering precise and minimally invasive tests, thereby enabling better disease management and treatment decisions for patients around the world.

What is VCYT known for?

Snapshot

Public US
Ownership
2006
Year founded
566
Employees
South San Francisco, United States
Head office
1 of 2
US Rank
Unknown
Sector
N/A
Sector rank
Loading Map...

Operations

Produtos e/ou serviços de Veracyte

  • Afirma Genomic Sequencing Classifier helps in identifying benign thyroid nodules to avoid unnecessary surgeries.
  • Envisia Genomic Classifier aids in diagnosing interstitial lung diseases, including idiopathic pulmonary fibrosis.
  • Percepta Genomic Sequencing Classifier is used for lung cancer risk assessment in patients with inconclusive lung nodules.
  • Prosigna Breast Cancer Prognostic Gene Signature Assay provides information on the risk of recurrence for breast cancer patients.
  • Decipher Prostate Genomic Classifier offers a risk assessment for prostate cancer progression and metastasis.
  • LymphMark, a lymphoma subtyping test, helps in the diagnosis and treatment planning for B-cell lymphoma.

equipe executiva do Veracyte

  • Mr. Marc A. StapleyCEO & Director
  • Ms. Rebecca ChambersExecutive VP & CFO
  • Dr. Phillip G. Febbo M.D.Chief Scientific & Medical Officer
  • Ms. Annie McGuireExecutive VP, General Counsel & Chief People Officer
  • Dr. John Leite Ph.D.Global Chief Commercial Officer
  • Dr. Keith Gligorich Ph.D.Senior Vice President of Global Operations
  • Mr. Jonathan WygantVP & Chief Accounting Officer
  • Mr. Steven FrenchSenior VP & Chief Information Officer
  • Ms. Karen PossematoSenior Vice President of Corporate Marketing, Communications & Commercial Operations
  • Ms. Corinne DananSenior Vice President

Connect with us

Disclaimer

Grafa is not a financial advisor. You should seek independent, legal, financial, taxation or other advice that relate to your unique circumstances.

Grafa is not liable for any loss caused, whether due to negligence or otherwise arising from the use of or reliance on the information provided directly or indirectly, by use of this platform.